[Ovarian carcinoma: surgery and polychemotherapy with cisplatin. Considerations on a clinical case].
The authors report their experience about a polychemotherapeutical treatment with CDDP in a woman bearer of 4th stage ovarian cancer. They shortly analyse the biologic features and acting mechanism of CDDP, and outline its indications and limits. The thorough regression observed in the case treated is related to the literature data pointing out the validity of this drug and its usefulness in particular neoplasiae and in carefully selected patients.